Deferred Tax Assets, Gross of PharmaCyte Biotech, Inc. from 30 Apr 2012 to 30 Apr 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: PharmaCyte Biotech, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 30 Apr 2012 to 30 Apr 2025.
PharmaCyte Biotech, Inc. Deferred Tax Assets, Gross for the quarter ending 30 Apr 2025 was $16,914,188, a 4.2% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Gross, Quarterly (USD)

Deferred Tax Assets, Gross, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Deferred Tax Assets, Gross (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$16,914,188	+$678,157	+4.2%	30 Apr 2025	10-K	11 Aug 2025	2025	FY
Q1 2024	$16,236,031	+$6,690	+0.04%	30 Apr 2024	10-K	11 Aug 2025	2025	FY
Q1 2023	$16,229,341	+$470,940	+3%	30 Apr 2023	10-K	13 Aug 2024	2024	FY
Q1 2022	$15,758,401	-$739,798	-4.5%	30 Apr 2022	10-K	31 Jul 2023	2023	FY
Q1 2021	$16,498,199	+$969,241	+6.2%	30 Apr 2021	10-K	28 Jul 2022	2022	FY
Q1 2020	$15,528,958	+$1,341,187	+9.5%	30 Apr 2020	10-K	10 Aug 2021	2021	FY
Q1 2019	$14,187,771	+$952,170	+7.2%	30 Apr 2019	10-K	13 Aug 2020	2020	FY
Q1 2018	$13,235,601	-$3,164,859	-19%	30 Apr 2018	10-K	13 Aug 2019	2019	FY
Q1 2017	$16,400,460	-$273,272	-1.6%	30 Apr 2017	10-K	20 Jul 2018	2018	FY
Q1 2016	$16,673,732	+$3,547,395	+27%	30 Apr 2016	10-K	27 Jul 2017	2017	FY
Q1 2015	$13,126,337	-$8,757,825	-40%	30 Apr 2015	10-K	29 Jul 2016	2016	FY
Q1 2014	$21,884,162	+$34,341,185		30 Apr 2014	10-K/A	19 Jan 2016	2015	FY
Q1 2013	$12,457,023	-$24,657,352	-202%	30 Apr 2013	10-K	04 Aug 2014	2014	FY
Q1 2012	$12,200,329			30 Apr 2012	10-K	29 Jul 2013	2013	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.